Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Myalepta 3 mg powder for solution for injection {equilateral_black_triangle}

Active Ingredient:
metreleptin
Company:  
Amryt Pharmaceuticals DAC See contact details
ATC code: 
A16AA07
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Myalepta (metreleptin) Healthcare Professional Guide

{healthcare_pro_orange} For Healthcare Professionals

Healthcare professional guide contains information on the specific risks associated with Myalepta and the measures designed to address them along with the potentially serious adverse drug reactions.

{pdf_link}

Myalepta (metreleptin) Patient Care Guide

This document contains important risk minimisation information for patients and their carers.

{pdf_link}

Myalepta (metreleptin) Specialist Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

This brochure is for Specialist Prescribers of Myalepta only and provides guidance on determining the right dose, training the patient to prepare and inject and prescribing.

{pdf_link}

Myalepta (metreleptin) Patient Dose Information Card

Provides patients and their carers important information on how to reconstitute and administer Myalepta (metreleptin).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Amryt Pharmaceuticals DAC
Company image
Address
45 Mespil Road, Dublin4, D04 W2F1, Ireland
WWW
http://www.amrytpharma.com
Telephone
+353 1 518 0200
Medical Information Direct Line
+44 1604 549 952
Medical Information e-mail
[email protected]
Customer Care direct line
00800 4447 4447